Christopher Starr, MD, FACS, highlights ways Demodex blepharitis can impact quality of life for affected patients.
Overcoming Challenges in Diagnosis and Management of Demodex Blepharitis
Dr Starr addresses long-term consequences associated with nontreatment of Demodex blepharitis.
Symptoms non-unique to DB, such as itching and scratching, may lead to misdiagnosis.
Dr Starr provides considerations for navigating diagnostic challenges related to Demodex blepharitis.
Therapies such as tee tree oil and other OTC agents are evaluated in the management of Demodex blepharitis.
A medical expert highlights a new FDA-approved medication as a key treatment in Demodex blepharitis.
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
AI Helps Managed Care Identify High-Risk Patients Sooner and More Precisely | AMCP Nexus 2025
2
Real-World Study Shows $330,000 Cost Difference Between CAR T and BiTE Therapies | AMCP Nexus 2025
3
Payers Are Bracing for the Specialty Trend of the Future | AMCP Nexus 2025
4
Cardiovascular, Renal and Metabolic Conditions Increasingly Prevalent, Expensive in Medicare Fee-For-Service Population | AMCP Nexus 2025
5
